文献速递胃肠外科围术期管理与 ERAS

袖状胃切除与袖状胃切除加转流术反流性食管炎发生率对比

Incidence of de novo gastroesophageal reflux disease following sleeve gastrectomy versus sleeve gastrectomy with transit bipartition: a retrospective cohort study.
PubMed 文献 · Surg Endosc · 2025-10-03

该回顾性队列研究纳入215例患者,比较袖状胃切除(SG)与袖状胃切除加转流术(SG-TB)的短期结局。术后12个月SG-TB组胃食管反流病(GERD)发生率显著更低(7.0% vs 29.0%),减重效果更优,且早期围术期安全性与SG相当。

要点

  • SG-TB术后12个月GERD发生率显著低于SG(7.0% vs 29.0%)。
  • SG-TB减重效果优于SG,%EWL和%TWL均更高。
  • SG是术后新发GERD的独立危险因素(OR 4.536)。

核心结论

  • SG-TB较SG显著降低术后GERD风险并带来更优短期减重,不增加围术期并发症。

研究设计与样本

  • 回顾性队列研究,纳入2022年1月至12月行SG(n=100)或SG-TB(n=115)的215例患者,年龄16-65岁,BMI≥27.5 kg/m2(合并2型糖尿病)或≥32.5 kg/m2。

主要发现

  • 术后12个月,SG-TB组%EWL为112.0±38.2% vs SG组97.2±25.5%(p=0.001)。
  • 术后12个月,SG-TB组%TWL为33.8±7.4% vs SG组31.1±6.4%(p=0.006)。
  • 术后12个月GERD发生率SG-TB组7.0% vs SG组29.0%(p<0.001)。
  • 多因素回归显示SG是术后新发GERD的独立危险因素(OR 4.536,95%CI 1.787-11.519,p=0.001)。
  • SG-TB手术时间更长,但早期术后安全性与SG相当。

临床怎么用

  • 对于关注术后反流风险及减重效果的减重手术患者,SG-TB可作为一种可选术式。
  • 术前应与患者充分沟通SG术后新发GERD风险较高,SG-TB手术时间较长。

局限性

  • 单中心回顾性设计,样本量有限,随访仅12个月,需多中心长期研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sleeve gastrectomy (SG) is the most commonly performed bariatric procedure worldwide; however, concerns persist regarding the development of de novo gastroesophageal reflux disease (GERD) after surgery. Sleeve gastrectomy with transit bipartition (SG-TB) has emerged as a potential alternative, aiming to reduce GERD incidence while achieving superior weight loss outcomes. This study aimed to compare short-term outcomes of GERD, weight loss, and perioperative safety between SG and SG-TB. METHODS: A retrospective cohort study was conducted with 215 patients who underwent SG (n = 100) or SG-TB (n = 115) between January and December 2022. Eligible patients were aged 16-65 years with a body mass index (BMI) of ≥ 27.5 kg/m2 (with type 2 diabetes) or ≥ 32.5 kg/m2. GERD incidence was evaluated using the gastroesophageal reflux disease questionnaire (GERD-Q) and endoscopy 12 months after surgery. Weight loss was measured by percentage total weight loss (%TWL) and percentage excess weight loss (%EWL). Operative time, estimated blood loss, length of hospital stay, and 30-day postoperative complications were also compared. RESULTS: At 12 months, the SG-TB group demonstrated superior weight loss (%EWL: 112.0 ± 38.2% vs. 97.2 ± 25.5%, p = 0.001; %TWL: 33.8 ± 7.4% vs. 31.1 ± 6.4%, p = 0.006). The incidence of GERD was significantly lower in the SG-TB group (7.0% vs. 29.0%, p < 0.001). Multivariate regression analysis identified SG as an independent risk factor for developing de novo GERD postoperatively (OR 4.536, 95% CI 1.787-11.519, p = 0.001). SG-TB was associated with longer operative time but showed comparable early postoperative safety to SG. CONCLUSIONS: SG-TB significantly reduced the risk of postoperative GERD and resulted in superior short-term weight loss compared to SG, without increasing perioperative complication rates. Further multicenter, long-term studies are needed to validate these findings.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Wang J, Ni L, Li T, et al. Incidence of de novo gastroesophageal reflux disease following sleeve gastrectomy versus sleeve gastrectomy with transit bipartition: a retrospective cohort study. Surg Endosc. 2025. PMID: 41042344. doi:10.1007/s00464-025-12276-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。